Follow
Ana Barbas
Ana Barbas
Bayer Pharma CGT
Verified email at bayer.com - Homepage
Title
Cited by
Cited by
Year
The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities
D Schaeffer, B Tsanova, A Barbas, FP Reis, EG Dastidar, ...
Nature structural & molecular biology 16 (1), 56-62, 2009
3432009
Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex
C Frazão, CE McVey, M Amblar, A Barbas, C Vonrhein, CM Arraiano, ...
Nature 443 (7107), 110-114, 2006
2492006
Challenges in antibody development against Tn and Sialyl-Tn antigens
LR Loureiro, MA Carrascal, A Barbas, JS Ramalho, C Novo, P Delannoy, ...
Biomolecules 5 (3), 1783-1809, 2015
1042015
Characterization of the functional domains of Escherichia coli RNase II
M Amblar, A Barbas, AM Fialho, CM Arraiano
Journal of molecular biology 360 (5), 921-933, 2006
842006
New insights into the mechanism of RNA degradation by ribonuclease II: identification of the residue responsible for setting the RNase II end product
A Barbas, RG Matos, M Amblar, E Lopez-Vinas, P Gomez-Puertas, ...
Journal of biological chemistry 283 (19), 13070-13076, 2008
632008
The role of the S1 domain in exoribonucleolytic activity: substrate specificity and multimerization
M Amblar, A Barbas, P Gomez-Puertas, CM Arraiano
Rna 13 (3), 317-327, 2007
592007
RNase R mutants elucidate the catalysis of structured RNA: RNA-binding domains select the RNAs targeted for degradation
RG Matos, A Barbas, CM Arraiano
Biochemical Journal 423 (2), 291-301, 2009
572009
Notch-out for breast cancer therapies
M Lamy, A Ferreira, JS Dias, S Braga, G Silva, A Barbas
New biotechnology 39, 215-221, 2017
522017
A single mutation in Escherichia coli ribonuclease II inactivates the enzyme without affecting RNA binding
M Amblar, CM Arraiano
The FEBS journal 272 (2), 363-374, 2005
502005
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
LR Loureiro, DP Sousa, D Ferreira, W Chai, L Lima, C Pereira, CB Lopes, ...
Scientific reports 8 (1), 12196, 2018
432018
Determination of key residues for catalysis and RNA cleavage specificity: one mutation turns RNase II into a “SUPER-ENZYME”
A Barbas, RG Matos, M Amblar, E Lopez-Vinas, P Gomez-Puertas, ...
Journal of biological chemistry 284 (31), 20486-20498, 2009
432009
Swapping the domains of exoribonucleases RNase II and RNase R: conferring upon RNase II the ability to degrade ds RNA
RG Matos, A Barbas, P Gómez‐Puertas, CM Arraiano
Proteins: Structure, Function, and Bioinformatics 79 (6), 1853-1867, 2011
322011
Biochemical Characterization of the RNase II Family of Exoribonucleases from the Human Pathogens Salmonella typhimurium and Streptococcus pneumoniae
S Domingues, RG Matos, FP Reis, AM Fialho, A Barbas, CM Arraiano
Biochemistry 48 (50), 11848-11857, 2009
282009
Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
J Goncalves, M Santos, R Acurcio, I Iria, L Gouveia, P Matos Brito, ...
Alimentary pharmacology & therapeutics 48 (5), 507-522, 2018
272018
RNase II: The finer details of the Modus operandi of a molecular killer
CM Arraiano, RG Matos, A Barbas
RNA biology 7 (3), 276-281, 2010
272010
The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells
J Sales-Dias, G Silva, M Lamy, A Ferreira, A Barbas
PloS one 14 (5), e0217002, 2019
222019
Characterizing ribonucleases in vitro: examples of synergies between biochemical and structural analysis
CM Arraiano, A Barbas, M Amblar
Methods in enzymology 447, 131-160, 2008
202008
Comparison of EMSA and SPR for the characterization of RNA–RNase II complexes
RG Matos, A Barbas, CM Arraiano
The Protein Journal 29, 394-397, 2010
172010
Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities
C Pinto, G Silva, AS Ribeiro, M Oliveira, M Garrido, VS Bandeira, ...
Journal of biotechnology 300, 70-77, 2019
162019
Modulating the RNA processing and decay by the exosome: altering Rrp44/Dis3 activity and end-product
FP Reis, A Barbas, AA Klauer-King, B Tsanova, D Schaeffer, ...
PloS one 8 (11), e76504, 2013
162013
The system can't perform the operation now. Try again later.
Articles 1–20